Crystallization: Presence of crystals of Nimodipine within the capsule solution.
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Caraco Pharmaceutical Laboratories, Ltd. to request your refund or repair — edit it as you like.
Subject: Recall D-003-2013 — Caraco Pharmaceutical Laboratories, Ltd. Caraco Pharmaceutical Laboratories Ltd. recalls Nimodipine Hello, I own a Caraco Pharmaceutical Laboratories Ltd. recalls Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per that is covered by recall D-003-2013 from Caraco Pharmaceutical Laboratories, Ltd.. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
